English
Polski
Español
українська
русский
Mesalamine in Crohn disease
What is the role of mesalamine (INN mesalazine) in the management of Crohn disease? Can it be used as the only maintenance drug, or rather should it be a part of combination treatment?
2019-11-19
What is the role of mesalamine (INN mesalazine) in the management of Crohn disease? Can it be used as the only maintenance drug, or rather should it be a part of combination treatment?
Is fecal microbiota transplantation (FMT) beneficial for patients with irritable bowel syndrome (IBS)?
Should proton pump inhibitors (PPIs) be prescribed in patients treated with nonsteroidal anti-inflammatory drugs (NSAIDs)?
What are the principles of pain management in patients with chronic pancreatitis? Can we use strong opioids?
Should proton pump inhibitors (PPIs) be prescribed in patients treated with oral glucocorticoids?
What are the results of surgical treatment of gastroesophageal reflux disease? Is symptom resolution permanent? What are the most frequent and most severe complications?
What should be the management of an asymptomatic pancreatic cyst >5 cm in diameter?
Would you prescribe proton pump inhibitors (PPIs) for patients with intestinal metaplasia of the gastroesophageal junction when the biopsy was taken from a Z line with <1 cm of variability?
Which patients with gastroesophageal reflux disease should be referred for surgical treatment?
How should we assess the effectiveness of oral supplementation of pancreatic enzymes?
McMaster Textbook of Internal Medicine acknowledges the important contribution of Cochrane Canada and its authors in development of the textbook.